Holders · period archive

MLTX · Moonlake Immunotherapeutics

Q1 2024 13F holders among managers we track latest ownership dossier

Ticker: MLTX
Type: Equity
Class: CLASS A ORD
Total reported value ($000, long equity)

Manager	Report date	Value	Shares